relapsed pediatric all

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

Recruiting
  • Relapsed Pediatric ALL
  • +2 more
  • In Vitro T cells depletion using CliniMCAS system
  • Shanghai, China
    Shanghai Children's Medical Center
Sep 28, 2022

Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed

Recruiting
  • Relapsed Non Hodgkin Lymphoma
  • +2 more
  • autologous CD19-directed chimeric antigen receptor (CAR) T-cells
  • Calgary, Alberta, Canada
  • +5 more
Jul 18, 2022

Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)

Recruiting
  • Relapsed Pediatric ALL
  • +3 more
  • Kansas City, Missouri
    Children's Mercy Hospital
Jul 1, 2022

Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia Trial in China (pCAR-19B cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • pCAR-19B cells
  • Beijing, Beijing, China
  • +9 more
May 19, 2022

Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia Trial in Wuhan (pCAR-19B cells)

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • pCAR-19B cells
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Mar 16, 2022

Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,

Terminated
  • Recurrent Pediatric ALL
  • +3 more
  • Los Angeles, California
  • +4 more
Feb 22, 2021